FDA product code LGL: Assay, Bart'S, Hemoglobin

LGL is the FDA product code for assay, bart's, hemoglobin. It is a Class II device, regulated under 21 CFR 864.7500 and reviewed by the Hematology panel. FDA has cleared 2 510(k) submissions under LGL. The average 510(k) review took 110 days (median 110).

Classification

FieldValue
Device nameAssay, Bart'S, Hemoglobin
Device classClass II
Regulation21 CFR 864.7500
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every LGL clearance

Top LGL applicants

ApplicantClearancesLatest
Isolab, Inc.21981-05-29

Most recent LGL clearances

510(k)ApplicantDeviceDecision dateReview days
K810976Isolab, Inc.ALPHA-THAL SCREEN TM CONTROL1981-05-2949
K801771Isolab, Inc.ALPHA-THAL SCREEN 20 TEST KIT & 100 KIT1981-01-16172

Recalls for LGL devices

openFDA lists no recalls for product code LGL.

Frequently asked questions

What is FDA product code LGL?

LGL is the FDA product code for assay, bart's, hemoglobin. It is a Class II device, regulated under 21 CFR 864.7500 and reviewed by the Hematology panel.

What device class is LGL?

Class II, regulation 21 CFR 864.7500. Typical premarket route: 510(k).

How long does a 510(k) take for product code LGL?

Across 2 cleared submissions the average was 110 days from receipt to decision (median 110).

Which companies have the most LGL clearances?

Isolab, Inc. (2).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times